Synphilin in normal human brains and in synucleinopathies: Studies with new antibodies

Acta Neuropathologica

Volumn 105, Issue 2, 2003, Pages 177-184

  Murray, Ian V J ^a   Medford, Marlon A ^a   Guan, Hong Ping ^a   Rueter, Susan M ^a   Trojanowski, John Q ^a   Lee, Virginia M Y ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Dementia with Lewy bodies; Lewy bodies; Multiple system atrophy; Parkinson's disease; Synuclein

Indexed keywords

ALPHA SYNUCLEIN; BRAIN EXTRACT; BUFFER; LIPID; NEUROPEPTIDE; POLYCLONAL ANTIBODY; SODIUM CHLORIDE; SYNPHILIN; SYNUCLEIN; TRITON X 100; UNCLASSIFIED DRUG; UREA; ANTIBODY; CARRIER PROTEIN; DIAGNOSTIC AGENT; NERVE PROTEIN; RECOMBINANT PROTEIN; SNCAIP PROTEIN, HUMAN;

ALZHEIMER DISEASE; ARTICLE; BIOCHEMISTRY; BRAIN CORTEX; BRAIN DEGENERATION; BRAIN TISSUE; CELL INCLUSION; CELL LINE; CEREBELLUM; CONTROLLED STUDY; DEMENTIA; GENE MUTATION; GENETIC CODE; GENETIC LINKAGE; GENETIC TRANSFECTION; GLIA; HIPPOCAMPUS; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LEWY BODY; MOLECULAR WEIGHT; NERVE CELL; NUCLEOTIDE SEQUENCE; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN INTERACTION; PROTEIN LOCALIZATION; PURKINJE CELL; PYRAMIDAL NERVE CELL; SHY DRAGER SYNDROME; SOLUBILITY; SUBSTANTIA NIGRA; TWO HYBRID SYSTEM; ADULT; AGED; ANIMAL; BRAIN; CELL CULTURE; COMPARATIVE STUDY; DEGENERATIVE DISEASE; FEMALE; IMMUNOLOGY; MALE; METABOLISM; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADULT; AGED; AGED, 80 AND OVER; ANIMALS; ANTIBODIES; BRAIN; CARRIER PROTEINS; CELLS, CULTURED; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LEWY BODIES; MALE; NERVE TISSUE PROTEINS; NEURODEGENERATIVE DISEASES; NEUROGLIA; NEURONS; RECOMBINANT PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 0037313282     PISSN: 00016322     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00401-002-0629-2     Document Type: Article

References (35)

1. Adams JD Jr, Chang ML, Klaidman L (2001) Parkinson's disease-redox mechanisms. Curr Med Chem 8:809-814
2. Betarbet R, Sherer TB, MacKenzie G, Garcia-Osuna M, Panov AV, Greenamyre JT (2000) Chronic systemic pesticide exposure reproduces features of Parkinson's disease. Nat Neurosci 3:1301-1306
3. Biere AL, Wood SJ, Wypych J, Steavenson S, Jiang Y, Anafi D, Jacobsen FW, Jarosinski MA, Wu GM, Louis JC, Martin F, Narhi LO, Citron M (2000) Parkinson's disease-associated alpha-synuclein is more fibrillogenic than beta-and gamma-synuclein and cannot cross-seed its homologs. J Biol Chem 275:34574-34579
4. Butterfield DA, Kanski J (2001) Brain protein oxidation in age-related neurodegenerative disorders that are associated with aggregated proteins. Mech Ageing Dev 122:945-962
5. Chung KK, Zhang Y, Lim KL, Tanaka Y, Huang H, Gao J, Ross CA, Dawson VL, Dawson TM (2001) Parkin ubiquitinates the alpha-synuclein-interacting protein, synphilin-1: implications for Lewy-body formation in Parkinson disease. Nat Med 7:1144-1150
6. Cohlberg JA, Li J, Uversky VN, Fink AL (2002) Heparin and other glycosaminoglycans stimulate the formation of amyloid fibrils from alpha-synuclein in vitro. Biochemistry 41:1502-1511
7. Crowther RA, Jakes R, Spillantini MG, Goedert M (1998) Synthetic filaments assembled from C-terminally truncated alpha-synuclein. FEBS Lett 436:309-312
8. Crowther RA, Daniel SE, Goedert M (2000) Characterisation of isolated alpha-synuclein filaments from substantia nigra of Parkinson's disease brain. Neurosci Lett 292:128-130
9. Engelender S, Kaminsky Z, Guo X, Sharp AH, Amaravi RK, Kleiderlein JJ, Margolis RL, Troncoso JC, Lanahan AA, Worley PF, Dawson VL, Dawson TM, Ross CA (1999) Synphilin-1 associates with alpha-synuclein and promotes the formation of cytosolic inclusions. Nat Genet 22:110-114
10. Engelender S, Wanner T, Kleiderlein JJ, Wakabayashi K, Tsuji S, Takahashi H, Ashworth R, Margolis RL, Ross CA (2000) Organization of the human synphilin-1 gene, a candidate for Parkinson's disease. Mamm Genome 11:763-766
11. Feany MB, Bender WW (2000) A Drosophila model of Parkinson's disease. Nature 404:394-398
12. Giasson BI, Murray IV, Trojanowski JQ, Lee VM-Y (2001) A Hydrophobic stretch of 12 amino acid residues in the middle of alpha-synuclein is essential for filament assembly. J Biol Chem 276:2380-2386
13. Gomez-Tortosa E, Ingraham AO, Irizarry MC, Hyman BT (1998) Dementia with Lewy bodies. J Am Geriatr Soc 46: 1449-1458
14. Gomez-Tortosa E, Newell K, Irizarry MC, Sanders JL, Hyman BT (2000) Alpha-Synuclein immunoreactivity in dementia with Lewy bodies: morphological staging and comparison with ubiquitin immunostaining. Acta Neuropathol (Berl) 99:352-357
15. Hashimoto M, Rockenstein E, Mante M, Mallory M, Masliah E (2001) Beta-Synuclein inhibits alpha-synuclein aggregation. A possible role as an anti-parkinsonian factor. Neuron 32:213-223
16. Iseki E, Takayama N, Furukawa Y, Marui W, Nakai T, Miura S, Ueda K, Kosaka K (2002) Immunohistochemical study of synphilin-1 in brains of patients with dementia with Lewy bodies - synphilin-1 is non-specifically implicated in the formation of different neuronal cytoskeletal inclusions. Neurosci Lett 326:211-215
17. Jenner P, Olanow CW (1998) Understanding cell death in Parkinson's disease. Ann Neurol 44:S72-S84
18. Kahle PJ, Neumann M, Ozmen L, Muller V, Odoy S, Okamoto N, Jacobsen H, Iwatsubo T, Trojanowski JQ, Takahashi H, Wakabayashi K, Bogdanovic N, Riederer P, Kretzschmar HA, Haass C (2001) Selective insolubility of alpha-synuclein in human Lewy body diseases is recapitulated in a transgenic mouse model. Am J Pathol 159:2215-2225
19. Kawamata H, McLean PF, Sharma N, Hyman BT (2001) Interaction of alpha-synuclein and synphilin-1: effect of Parkinson's disease-associated mutations. J Neurochem 77:929-39
20. Kruger R, Kuhn W, Muller T, Woitalla D, Graeber M, Kosel S, Przuntek H, Epplen JT, Schols L, Riess O (1998) Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease. Nat Genet 18:106-108
21. Masliah E, Rockenstein E, Veinbergs I, Mallory M, Hashimoto M, Takeda A, Sagara Y, Sisk A, Mucke L (2000) Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders. Science 287:1265-1269
22. Nagai K, Thogersen HC (1987) Synthesis and sequence-specific proteolysis of hybrid proteins produced in Escherichia coli. Methods Enzymol 153:461-481
23. Neystat M, Rzhetskaya M, Kholodilov N, Burke R (2002) Analysis of synphilin-1 and synuclein interactions by yeast two-hybrid-galactosidase liquid assay. Neurosci Lett 325:119-123
24. O'Farrell C, Murphy DD, Petrucelli L, Singleton AB, Hussey J, Farrer M, Hardy J, Dickson DW, Cookson MR (2001) Transfected synphilin-1 forms cytoplasmic inclusions in HEK293 cells. Brain Res Mol Brain Res 97:94-102
25. Palmer I, Wingfield PT (1995) Preparation and extraction of insoluble (inclusion body) proteins from Escherichia coli. In: Coligan JE, Dunn BM, Ploegh HL, Speicher DW, Wingfield PT (eds) Current protocols in protein science. Wiley, New York, pp 6.3.1-6.3.15
26. Polymeropoulos MH, Lavedan C, Leroy E, Ide SE, Dehejia A, Dutra A, Pike B, Root H, Rubenstein J, Boyer R, Stenroos ES, Chandrasekharappa S, Athanassiadou A, Papapetropoulos T, Johnson WG, Lazzarini AM, Duvoisin RC, Di Iorio G, Golbe LI, Nussbaum RL (1997) Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science 276: 2045-2047
27. Ribeiro CS, Carneiro K, Ross CA, Menezes JR, Engelender S (2002) Synphilin-1 is developmentally localized to synaptic terminals and its association with synaptic vesicles is modulated by alpha-synuclein. J Biol Chem 277:23927-23933
28. Sayre LM, Smith MA, Perry G (2001) Chemistry and biochemistry of oxidative stress in neurodegenerative disease. Curr Med Chem 8:721-738
29. Spillantini MG, Schmidt ML, Lee VM-Y, Trojanowski JQ, Jakes R, Goedert M (1997) Alpha-Synuclein in Lewy bodies. Nature 388:839-840
30. Spillantini MG, Crowther RA, Jakes R, Cairns NJ, Lantos PL, Goedert M (1998) Filamentous alpha-synuclein inclusions link multiple system atrophy with Parkinson's disease and dementia with Lewy bodies. Neurosci Lett 251:205-208
31. Trojanowski JQ, Schuck T, Schmidt ML, Lee VM-Y (1989) Distribution of tau proteins in the normal human central and peripheral nervous system. J Histochem Cytochem 37:209-215
32. Uversky VN, Li J, Fink AL (2001) Evidence for a partially-folded intermediate in alpha-synuclein fibril formation. J Biol Chem 276:10737-10744
33. Wakabayashi K, Engelender S, Yoshimoto M, Tsuji S, Ross CA, Takahashi H (2000) Synphilin-1 is present in Lewy bodies in Parkinson's disease. Ann Neurol 47:521-523
34. Wakabayashi K, Engelender S, Tanaka Y, Yoshimoto M, Mori F, Tsuji S, Ross CA, Takahashi H (2002) Immunocytochemical localization of synphilin-1, an alpha-synuclein-associated protein, in neurodegenerative disorders. Acta Neuropathol 103: 209-214
35. Wood SJ, Wypych J, Steavenson S, Louis JC, Citron M, Biere AL (1999) Alpha-Synuclein fibrillogenesis is nucleation-dependent. Implications for the pathogenesis of Parkinson's disease. J Biol Chem 274:19509-19512